Treatment of shoulder pain in patients of paralysis due to stroke under ultrasound guidance by bupivacaine and radiofrequency ablatio
- Conditions
- Health Condition 1: G819- Hemiplegia, unspecified
- Registration Number
- CTRI/2019/10/021733
- Lead Sponsor
- Regional Institute of Medical Sciences Imphal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Diagnosed as acute stroke within the previous 12 months with hemiplegic shoulder pain.
Pain severity with minimum score of 5 based on 10 scale VAS.
Willingness to comply with treatment and follow-up assessments.
1.Cognitive deficit that precluded patients from reliably using subjective outcome measures scales [Mini Mental State Examination]
2.Allergy to proposed injection agents (lidocaine and Bupivacaine)
3.Degenerative changes at the glenohumeral joint as shown by a standard anteroposterior radiograph
4.Any recent febrile or infectious disease (systemic & local)
5.History of any malignancy (including hematologic and non-hematologic malignancies)
6.Previous history of systemic inflammatory joint disease like rheumatoid arthritis, gout, etc
7.Metabolic or systemic disease like ischemic heart disease, hepatitis, uncontrolled diabetes mellitus
8.Any trauma, fracture, bony malformation or dislocation of shoulder
9.History of autoimmune and hematological disorders
10.Intra or periarticular steroid injection to shoulder in previous 2 months
11.Platelet counts of less than 150,000 per micro liter
12.Cardiac arrhythmia or a pacemaker
13.Hemorrhagic stroke
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Visual Analog Scale (VAS) <br/ ><br>2. Shoulder Range Of Motion (ROM) <br/ ><br>Timepoint: At 1st, 4th, 12th and 24th week <br/ ><br>
- Secondary Outcome Measures
Name Time Method Shoulder Pain And Disability Index (SPADI)Timepoint: 1, 4, 12 and 24 weeks